Monoamine oxidase (MAO) Inhibitors

Monoamine oxidase (MAO) inhibitors are a group of pharmaceutical drugs that play a crucial role in the treatment of various psychiatric and neurological disorders MAO inhibitors work by blocking the action of an enzyme called monoamine oxidase which is responsible for breaking down neurotransmitters such as serotonin dopamine and norepinephrine By inhibiting this enzyme MAO inhibitors increase the concentration of these neurotransmitters in the brain leading to improved mood and alleviation of symptoms associated with depression anxiety and other related conditions Our company offers a range of effective and reliable MAO inhibitors that have been extensively tested and proven to provide significant therapeutic benefits

Catalog Number	Chemical Name	CAS #	Price
EI-0626	Clorgyline hydrochloride	17780-75-5	Online Inquiry
EI-1015	Furazolidone	67-45-8	Online Inquiry
EI-1413	MAO-A/MAO-B Inhibitor	307548-94-3	Online Inquiry
EI-1511	Moclobemide	71320-77-9	Online Inquiry
EI-1676	Pargyline hydrochloride	306-07-0	Online Inquiry
EI-1860	Rasagiline mesylate	161735-79-1	Online Inquiry
EI-1937	Safinamide	133865-89-1	Online Inquiry

Application

Monoamine oxidase (MAO) inhibitors have a wide range of applications in both medicine and neuroscience research In the field of medicine these inhibitors are primarily used as antidepressants specifically for the treatment of depression and anxiety disorders By inhibiting the activity of MAO enzymes which regulate the breakdown of neurotransmitters like serotonin and dopamine MAO inhibitors increase the levels of these neurotransmitters in the brain effectively improving mood and alleviating symptoms of depression

Aside from their therapeutic use MAO inhibitors also play a crucial role in neuroscience research They are commonly used to study the function of neurotransmitters and their role in various neurological disorders such as Parkinson's disease and Alzheimer's disease By inhibiting MAO activity researchers can better understand the impact of neurotransmitter dysregulation on these conditions and explore potential treatment strategies

Furthermore MAO inhibitors have demonstrated potential applications in the field of addiction treatment By inhibiting the breakdown of neurotransmitters involved in addiction pathways these inhibitors can help reduce cravings and withdrawal symptoms making them a valuable tool in substance abuse therapy

In summary the applications of MAO inhibitors extend to the treatment of depression and anxiety disorders as well as research on neurological disorders and addiction With their ability to modulate neurotransmitter levels MAO inhibitors hold great promise in improving mental health and advancing our understanding of the brain

Please note that all services are for research use only. Not intended for any clinical use.

Monoamine oxidase (MAO) Inhibitors